Bioceres Crop Solutions Corp.

NasdaqGS:BIOX Stock Report

Market Cap: US$791.6m

Bioceres Crop Solutions Future Growth

Future criteria checks 4/6

Bioceres Crop Solutions is forecast to grow earnings and revenue by 36.7% and 18.8% per annum respectively while EPS is expected to grow by 36.2% per annum.

Key information

36.7%

Earnings growth rate

36.2%

EPS growth rate

Chemicals earnings growth15.3%
Revenue growth rate18.8%
Future return on equityn/a
Analyst coverage

Low

Last updated06 Mar 2024

Recent future growth updates

Recent updates

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Earnings and Revenue Growth Forecasts

NasdaqGS:BIOX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2026781115N/A801
6/30/20255987598883
6/30/20244922978624
12/31/202345522630N/A
9/30/2023409142650N/A
6/30/202341919-203N/A
3/31/202341615-126N/A
12/31/2022391-19-311N/A
9/30/2022389-8-47-36N/A
6/30/2022328-7-27-18N/A
3/31/2022308-2-19N/A
12/31/20212754-12-2N/A
9/30/20212311-27-12N/A
6/30/2021207-7-20-6N/A
3/31/2021174-5-36-24N/A
12/31/2020164-7-24-13N/A
9/30/20201783-9-4N/A
6/30/2020172359N/A
3/31/202017401418N/A
12/31/2019167-182832N/A
9/30/2019167-231822N/A
6/30/2019160-182630N/A
3/31/2019142-262933N/A
12/31/2018145-82227N/A
9/30/2018129-133137N/A
6/30/2018133-111318N/A
6/30/201794-12N/A19N/A
12/31/201641-6N/A-1N/A
12/31/20155-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BIOX's forecast earnings growth (36.7% per year) is above the savings rate (2.3%).

Earnings vs Market: BIOX's earnings (36.7% per year) are forecast to grow faster than the US market (13.4% per year).

High Growth Earnings: BIOX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BIOX's revenue (18.8% per year) is forecast to grow faster than the US market (8.2% per year).

High Growth Revenue: BIOX's revenue (18.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BIOX's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.